Teriparatide has been shown to increase bone tumors (osteosarcoma) in rats. However, this occurred at doses higher than the usual human dose. It is unknown if this medication can cause bone tumors in humans. Therefore, this medication should not be used by people with increased risk for bone tumors (including people with Paget's disease of bone or people who had radiation treatment involving the bones).
Patient Question:Hello. I’ve been on Fosamax for 6 years and as of now, my deviations are as bad as they were when I first started; any... Read more »
We all must know by now that Forteo® (teriparatide) is the only osteoporosis drug that slows bone resorption (bone loss) and accelerates... Read more »
Dr. Susan Bukata and Dr. J. Edward Puzas, at the University of Rochester Medical Center New York,recently found that Forteo, a genetically... Read more »
While bisphosphonates—Fosamax, Boniva, et. al.—are certainly the most common osteoporosis drugs, they’re not the only ones you might... Read more »
Welcome to our Member Interviews, today we'll be talking to Taape about her experiences with Forteo. Before we start, here's some... Read more »
This is a study to determine if daily doses of Forteo reduce back pain better than weekly doses of Actonel in women with osteoporosis who have back... Read more »
According to a new study, hip-strengthening exercises may reduce patellofemoral pain in women runners. This common type of knee pain is caused by the... Read more »
Source: eOrthopod
Physical Therapists faced with patients who have knee pain must make sure the problem is really coming from the knee. This is true for all... Read more »